Search PubMed⌕ Search

Biomedical subjects

D B Anderson

Publications and source records attributed to D B Anderson.

At least 37 records · Page 2Linked to original sources

The effect of ractopamine on beta-adrenoceptor density and affinity in porcine adipose and skeletal muscle tissue.

We have evaluated the effect of feeding ractopamine (Rac), a phenethanolamine lean enhancer being developed for commercial use in finishing pigs, on beta-adrenoceptor (beta-AR) number and ligand-receptor binding affinity in adipose and muscle tissues. Pigs weighing 78 +/- 1 kg were fed Rac (20 mg/kg of diet) for 0 (control), 1, 8, or 24 d before being killed at 105 +/- 1 kg BW. beta-adrenoceptor density (per milligram of protein) was decreased by Rac up to approximately 50% in both the middle and the outer layers of subcutaneous (SQ) adipose tissue. Orthogonal contrasts indicated significant (P < or = .05) linear effects of Rac in middle and outer SQ adipose tissue, and also a significant (P < or = .05) quadratic effect of Rac in the middle layer. Ractopamine did not affect the maximal binding (Bmax) of longissimus muscle. The relative affinity with which the beta-AR population of the tissues examined bound the radioligand ([3H]dihydroalprenolol) was not influenced by Rac. Likewise, feeding Rac had no effect on the affinity of the beta-AR for Rac. The data indicate that a Rac-induced reduction in the Bmax of adipose tissue may account for the diminished in vitro lipolytic potency of exogenous Rac after prolonged periods of Rac feeding, and that Rac-induced desensitization differs between adipose and skeletal muscle tissues.

Adipose Tissue↗

High incidence of clinical mastitis due to Staphylococcus aureus in two dairy herds with low milk cell counts.

Five dairy herds with a high incidence of clinical mastitis were investigated. Two of these herds had a high incidence of mastitis caused by Staphylococcus aureus yet had a relatively low rolling mean cell count. The mean cell counts of samples from clinical cases submitted by the dairymen from these two farms were significantly lower than the counts of similar samples submitted from the other farms. It is suggested that a possible explanation of the low cell count on these two farms was the proficiency of the dairy-men in detecting clinical mastitis.

Animal Husbandry↗

Skeletal muscle alpha-actin synthesis is increased pretranslationally in pigs fed the phenethanolamine ractopamine.

Ractopamine [1-(4-hydroxyphenyl-2-(1-methyl-3-(4-hydroxyphenyl)propylamino)ethanol] enhances protein accretion in skeletal muscle (sm) of pigs. Experiments were conducted to elucidate fractional protein synthesis (FSR) and mRNA abundance for alpha-actin in sm of pigs fed a 16% protein diet containing 20 parts/million ractopamine for 21 days. Pigs were infused for 6 h with [14C]lysine (80 microCi/h.pig); after infusion pigs were killed, and longissimus dorsi muscle samples were obtained for RNA isolation and measurement of [14C]lysine incorporation. FSR was determined in vivo by incorporation of [14C]lysine from the muscle free amino acid pool into purified sm alpha-actin. FSR of sm alpha-actin was 55% greater in ractopamine-treated pigs than in controls. Relative mRNA abundance of alpha-actin was determined by dot blot hybridization of 0.1-0.4 microgram RNA to human sm alpha-actin [32P]cDNA probe. Longissimus dorsi alpha-actin mRNA abundance was 2-fold greater in pigs fed ractopamine. Sm RNA was translated in vitro using a cell-free assay to determine pretranslational effects on other muscle proteins. Effects of ractopamine on muscle protein synthesis are not specific to sm alpha-actin, because other muscle proteins also were increased using the in vitro translation assay. These results indicate that the increase in sm accretion in pigs fed ractopamine is due in part to an increase in myofibrillar protein synthesis and that some of the increase can be accounted for by an increase in mRNA abundance for sm alpha-actin.

Actins↗

The effect of various levels of ractopamine hydrochloride on the performance and carcass characteristics of finishing swine.

Six trials involving 888 pigs (Study 1) and three trials involving 360 pigs (Study 2) were conducted at various geographical locations in the U.S. and Canada to evaluate the effect of ractopamine hydrochloride on the performance and carcass characteristics of finishing swine. All trials were conducted using a randomized complete block design. Trial data were pooled within study for statistical analysis. Pigs averaged approximately 64.5 kg (Study 1) and 65.9 kg (Study 2) initially and had ad libitum access to a 16% crude protein corn-soybean meal or barley-soybean meal diet. Ractopamine was included in the diet at 0, 2.5, 5, 10, 20 or 30 ppm (Study 1), or at 0, 5, 10, 15 or 20 ppm (Study 2); diets were fed for an average of 45 d (Study 1) and 50 d (Study 2) to a final weight of about 104.3 kg (Study 1) and 106.6 kg (Study 2). Carcass dissection data were collected in three of the six trials in Study 1 (0, 5 and 20 ppm ractopamine) and in all three trials in Study 2 (0, 5, 10, 15 and 20 ppm ractopamine). All ractopamine levels improved (P less than .05) ADG and feed: gain (Studies 1 and 2) above those of control pigs. Ractopamine levels of 10 to 30 ppm (Studies 1 and 2) improved (P less than .05) dressing percentage over controls. Pigs fed ractopamine at 5 and 20 ppm (Study 1) and 10, 15 and 20 ppm (Study 2) had increased (P less than .05) dissected leanness compared with controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Adipose Tissue↗

Elevation of a specific mRNA in longissimus muscle of steers fed ractopamine.

To address the hypothesis that some classes of growth promoters stimulate muscle protein synthesis in growing cattle, 23 crossbred steers were fed diets containing the phenethanolamine growth promoter ractopamine in a 140-d feeding trial. Steers received either no ractopamine, .18 or .36 mg.kg BW-1.d-1 ractopamine for 140 d or .36 or .72 mg.kg BW-1.d-1 ractopamine for 56 d. Longissimus muscle was obtained at slaughter and frozen in liquid N2. RNA was extracted by homogenization of pulverized frozen muscle in guanidinium isothiocyanate and centrifugation through cesium chloride. Polyadenylated mRNA was extracted by capture on oligo-dT columns. Ractopamine had no effect on total RNA or mRNA concentrations (P greater than .25). Hybridization of the RNA to a putative myosin light chain-1/3 (MLC-1/3) cDNA clone in a Northern blot indicated one heavy band (approximately 1 kb) with no evidence of extensive destruction of the RNA. A second, minor band (approximately 3 kb) also was observed in some samples. The MLC-1/3 cDNA clone was hybridized to 1- or 5-micrograms samples of total RNA, and the intensity of the resultant autoradiographs was quantified by laser densitometry. There was a statistical correlation between MLC-1/3 mRNA-micrograms RNA-1 and longissimus cross-sectional area (P less than .05) and average daily gain (P less than .025). The results suggest that ractopamine either increased the transcription of the putative MLC-1/3 gene and(or) increased the stability of MLC-1/3 mRNA in bovine longissimus muscle, either of which could result in an increase in specific myofibrillar protein synthesis.

Analysis of Variance↗

Effect of ractopamine on insulin sensitivity and response of isolated rat adipocytes.

In vitro effects of the phenethanolamine ractopamine on basal and insulin-stimulated lipid metabolism were determined in adipocytes isolated from epididymal fat pads of Sprague-Dawley rats. Ractopamine appeared to be equipotent to the catecholamine isoproterenol in stimulating basal lipolysis and inhibiting basal lipogenesis, producing maximum effects at 10(-6) M. Addition of a half-maximally stimulating dose of ractopamine (5 x 10(-8) M) to the incubation media decreased insulin sensitivity but not insulin responsiveness of the cells, stimulating lipolysis and inhibiting lipogenesis only in the presence of low media insulin concentrations. This effect was totally reversed by 10 microM/propranolol. Maximally effective concentrations of ractopamine (10(-6) M) significantly decreased both the sensitivity and responsiveness of the isolated adipocytes to insulin. Addition of 10 microM propranolol to the incubation media effectively reversed the lipolytic and anti-lipogenic effects of 10(-6) M ractopamine observed at media insulin concentrations greater than 25 microU/ml, whereas it only partially reduced the ractopamine-induced effects observed at lower insulin concentrations. The results demonstrate 1) that ractopamine has concentration-dependent effects on adipose tissue insulin sensitivity and responsiveness and 2) that these effects may be mediated, in part, through beta-adrenergic receptors.

Adipose Tissue↗

Muscle protein metabolism in finishing pigs fed ractopamine.

Forty crossbred barrows (average initial weight, 66.4 kg) were utilized to determine the effects of ractopamine (a phenethanolamine/beta adrenergic agonist) on protein accretion and synthesis, activities of cathepsins B, H, L and calcium-dependent proteinase and nucleic acid content of semitendinosus muscle (ST). All pigs were offered a 16% protein, mineral and vitamin fortified corn-soybean meal diet supplemented with either 0 or 20 ppm ractopamine for 14, 21, 28, 35 or 42 d. Protein synthesis (fractional rates) was studied in pigs at d 21 and 35; ST protease activities, protein and nucleic acid content were measured on d 14, 28 and 42. Ractopamine increased (P less than .01) ST total protein content and maintained RNA muscle concentration and total ST muscle RNA content. DNA content (mg/g ST) declined (P less than .05) upon ractopamine feeding, but total DNA per muscle remained unchanged except for d 42, when the ST muscles were largest. Fractional accretion rates (FAR) were 1.0 and 1.2% for control and ractopamine-fed pigs, respectively. Fractional protein synthesis rate (FSR) was higher (P less than .06) in ractopamine-fed pigs (6.1%/d) than in control pigs (4.4%/d). Fractional protein synthesis rate could account for the observed muscle hypertrophy and increased FAR. Estimated fractional breakdown rates (FBR = FSR - FAR) were 3.4%/d and 4.9%/d for control and ractopamine-fed pigs, respectively. The activities of the catheptic proteases and calcium-dependent proteinase were not affected by the treatments.

Adrenergic beta-Agonists↗

Effects of amperozide and azaperone on aggression and productivity of growing-finishing pigs.

Levels of aggression, activity and performance were determined in 270 pigs (initial wt 29.8 kg) injected with amperozide (1.0 mg/kg i.m.), azaperone (2.2 mg/kg i.m.) or saline (.1 ml/kg i.m.) immediately prior to mixing. Pigs had ad libitum access to feed in pens of 15, and six pens were allotted to each treatment. Each pen was video-taped for 48 h after injection. Aggression was determined by continuous observation and summarized for each 2-h period. Injuries on the ears and shoulders of each pig were scored prior to injection and 1, 2, 3 and 7 d after treatment. Eating, drinking and lying were determined by scan sampling at 2-min intervals and summarized for each 2-h period. Weight gain, feed consumption and efficiency were determined for periods ending on d 3, 7, 14, 28, 42, 56, 70 and 84. Both drugs reduced total fighting from 309.8 min for saline to 190.7 and 189.6 min for amperozide- and azaperone-treated pens, respectively (P less than .01). Treatment differences in aggression and lying were evident during the initial 6 h only. Amperozide resulted in fewer fights involving two pigs (197.3/pen) than did azaperone (260.2/pen) or saline (298.3/pen) (P less than .05). Injuries to the ears (P less than .01) and total injuries (P less than .05) were less severe in amperozide-treated pigs than in pigs on the other treatments.(ABSTRACT TRUNCATED AT 250 WORDS)

Aggression↗

Effect of various levels of avilamycin on the performance of growing-finishing swine.

A series of 12 trials involving 1,710 crossbred pigs was conducted at eight geographical locations in the United States to determine the effect of avilamycin on average daily gain (ADG), average daily feed (ADF) and feed-to-gain ratio (F/G) of growing-finishing swine. Eight of 12 trials evaluated avilamycin concentrations at 0, 5, 10, 20, 40 and 60 ppm, while an additional four trials evaluated avilamycin concentrations at 0, 10, 20 and 40 ppm in swine grower and finisher diets fed ad libitum. All trials were conducted using a randomized complete block design with data from the 12 trials pooled for statistical analysis. Pigs fed 5, 10, 20, 40 or 60 ppm avilamycin had increased (P less than .05) ADG over control pigs. No differences were detected for ADF between control and avilamycin-fed pigs. Pigs fed 10, 20, 40 or 60 ppm avilamycin had improved (P less than .05) F/G over control animals. Average daily gain, ADF and F/G for pigs fed 0, 5, 10, 20, 40 or 60 ppm avilamycin were: 749, 763, 767, 769, 771 and 771 g; 2.38, 2.40 2.39, 2.41, 2.38 and 2.38 kg; and 3.17, 3.15, 3.12, 3.13, 3.09 and 3.09, respectively. Linear plateau procedures showed that the effective dose range of avilamycin for the growing-finishing phase is 5 to 10 ppm for improving ADG and 10 to 60 ppm for improving F/G.

Administration, Oral↗

Improved reproductive performance from dairy cows treated with dinoprost tromethamine soon after calving.

The first-service conception rate for 74 commercial dairy cows that were given a single injection of dinoprost tromethamine (prostaglandin F(2)alpha THAM) between 14 and 28 d after calving was 56%. For 74 untreated control herdmates the rate was 47%. The average interval from calving to first oestrus was 57 d for treated cows and 70 d for the control group. The difference is significant at the P = 0.017 level. The advantage in the conception rate of treated over control group cows occurred mostly in cows with a blood progesterone concentration of less than 0.5 ng/ml at the time of treatment; this numbered about two-thirds of the cows in the trial. The results support the findings of a previous study.

Journal Article↗

Increased conception rate in dairy cows after early post partum administration of prostaglandin F2 alpha THAM.

Commercial dairy cows were given a routine injection of dinoprost tromethamine (prostaglandin F2 alpha THAM) in the early post partum period. The first service conception rate of 64 cows given a single 25 mg injection of dinoprost during the period 14 to 28 days after calving was 68 per cent, that of 64 untreated controls was 43 per cent. The difference was highly significant at the level P = 0.007. In cows with no blood progesterone and with basal progesterone concentrations at the time of treatment, indicating absence of an active corpus luteum, the mean conception rates for 30 treated and 38 control cows were 70 and 44 per cent, respectively, demonstrating that this is not a luteolytic effect. Although that implies a positive myometrial effect, the interval from calving to first service was not shortened in treated cows.

Animals↗

Estimating body fat in mature beagle bitches.

Body composition was determined in 24 female Beagle dogs ranging in age from 2 to 4 years (live weight 11.1 +/- 3.3 kg). Subcutaneous fat measurements were made using an ultrasonic probe device on the live animal and direct measurements after death. Measurements were made near the shoulder, mid-rib, last rib, mid-lumbar, and last lumbar areas. The actual fat measurement giving the highest correlation with body fat was the one made directly over the longissimus muscle near the last rib (r2 x 100 = 93.6). Multiple linear regression, using live weight and the last rib fat thickness measurement, estimated body fat with a standard error of 0.27 kg (r2 x 100 = 98.4). Body fat = 2.2 + (0.13 x fat thickness + (0.36 x live weight) where body fat and live weight were measured in kg and fat thickness in mm.

Adipose Tissue↗

Treatment of small cell carcinoma of the lung with methotrexate, doxorubicin, cyclophosphamide, and lomustine: a community-based study.

Forty-four patients with undifferentiated small cell carcinoma of the lung (SCCL) were diagnosed and treated at community hospitals. Patients with limited disease were treated with surgical resection or primary radiation therapy (RT) followed by chemotherapy; those with extensive disease received chemotherapy followed by RT if there was not a complete primary response. The chemotherapy used was a combination of methotrexate, doxorubicin, cyclophosphamide, and lomustine. Median survival for patients with both limited and extensive disease was 12 months, with a six-month survival of 89%. Half of the patients had recurrence in the lung. The toxicity was moderate and tolerable. We conclude that this combination chemotherapy plus radiation therapy carries acceptable toxicity and can be used in a community hospital to achieve response rates and survival of SCCL equivalent to that obtained in large cancer centers.

Adult↗